Skip to main content
. 2024 May 28;13(6):660. doi: 10.3390/antiox13060660
aPDT Antimicrobial photodynamic therapy
BOP Bleeding on probing
BTF Bio-enhanced turmeric formulation
CAL Clinical attachment level
CMS Carboxymethyl starch
COX-2 Cyclooxygenase-2
CS Chitosan
CRP C-reactive protein
DNA Deoxyribonucleic acid
EGF Epidermal growth factor
EMT Epithelial–mesenchymal transition
GI Gingival index
HNC Head and neck cancer
IL-1β Interleukin 1β
IL-6 Interleukin-6
IL-8 Interleukin-8
LDD Local drug delivery
MA Mefenamic acid
MDA Malondialdehyde
MDSC Myeloid-derived suppressor cells
MF Mucosal flexibility
MIT Modified intention to treat
MMT Montmorillonite
MO Mouth opening
MOMI Modified oral mucositis index
NF- κB Nuclear factor kappa B
NRS Numerical rating scale
OLP Oral lichen planus
OPMDs Oral potentially malignant disorders
OSCC Oral squamous carcinoma
OSMF Oral submucosal fibrosis
PBM Photobiomodulation
PCT Procalcitonin
PI Plaque index
PLA Poly lactide
PLGA Poly lactide-co-glicolide
PP Per protocol
PPD Periodontal probing depth
RANK Receptor activator of nuclear factor κB
RANKL Receptor activator of nuclear factor κΒ ligand
RAS Recurrent aphthous stomatitis
RIOM Radiation-induced oral mucositis
ROS Reactive oxygen species
PLGA Poly lactide-co-glicolide
SRP Scaling and root planing
SPT Surgical periodontal therapy
TGF-β Transforming growth factor β
TP Tongue protrusion
VAS Visual analog scale
8-OHdG 8-hydroxydeoxyguanosine